Frontiers in Oncology | Hematologic Malignancies

Review

Published on 14 Sep 2023

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms

in Hematologic Malignancies

Mario Henrique M. Barros
Paula Daniela S. Alves

Frontiers in Oncology

doi 10.3389/fonc.2023.1240359

7,311 views
5 citations

Brief Research Report

Published on 13 Sep 2023

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia

in Hematologic Malignancies

Ansel Nalin
Qiuhong Zhao
Timothy Voorhees
David Bond
Yazeed Sawalha
Walter Hanel
Audrey Sigmund
Kaitlin Annunzio
Lapo Alinari
Robert Baiocchi

Frontiers in Oncology

doi 10.3389/fonc.2023.1264387

2,414 views
1 citation

Case Report

Published on 13 Sep 2023

Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation

in Hematologic Malignancies

María Noel Spangenberg
Sofía Grille
Camila Simoes
Mariana Brandes
Joaquín Garcia-Luna
Ana Inés Catalán
Sabrina Ranero
Matilde Boada
Andreína Brugnini
Natalia Trias

Frontiers in Oncology

doi 10.3389/fonc.2023.1248964

2,766 views
3 citations

Original Research

Published on 12 Sep 2023

Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana

in Hematologic Malignancies

Carla Minoia
Simonetta Viviani
Erica Silvestris
Simone Palini
Francesca Parissone
Giuseppe De Palma
Anna Fedina
Gennaro Cormio
Attilio Guarini
Guido Gini

Frontiers in Oncology

doi 10.3389/fonc.2023.1252433

5,972 views
6 citations

Mini Review

Published on 11 Sep 2023

Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science

in Hematologic Malignancies

Senthil Velan Bhoopalan
Shruthi Suryaprakash
Akshay Sharma
Marcin W. Wlodarski

Frontiers in Oncology

doi 10.3389/fonc.2023.1236038

8,066 views
8 citations

Original Research

Published on 11 Sep 2023

Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib

in Hematologic Malignancies

Yurim Jeong
Se Been Kim
Chae-Eun Yang
Min Seo Yu
Wan-Su Choi
Youngwoo Jeon
Jung-Yeon Lim

Frontiers in Oncology

doi 10.3389/fonc.2023.1252658

3,915 views
4 citations

Original Research

Published on 08 Sep 2023

Extracorporeal light-chain elimination in myeloma with simple medium cutoff membrane hemodialysis: a retrospective cohort study

in Hematologic Malignancies

Christian W. Schaaf
Matthias C. Braunisch
Christopher Holzmann-Littig
Frederick Pfister
Liya Hannemann
Renate I. Hausinger
Mareike Verbeek
Christoph Schmaderer
Lutz Renders
Uwe Heemann

Frontiers in Oncology

doi 10.3389/fonc.2023.1193504

3,636 views
3 citations

Case Report

Published on 08 Sep 2023

Invasive splenic mucormycosis due to Rhizopus microsporus during chemotherapy for acute monocytic leukemia: a case report and literature review

in Hematologic Malignancies

Xiru Peng
Zixiu Wei
Lijuan Wang
Juan Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1237807

2,443 views
4 citations

Original Research

Published on 08 Sep 2023

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers

in Hematologic Malignancies

Anett Balikó
Zsolt Szakács
Béla Kajtár
Zsombor Ritter
Attila Gyenesei
Nelli Farkas
László Kereskai
István Vályi-Nagy
Hussain Alizadeh
László Pajor

Frontiers in Oncology

doi 10.3389/fonc.2023.1224733

2,574 views
2 citations

Case Report

Published on 07 Sep 2023

Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase

in Hematologic Malignancies

Emmanuella Oyogoa
Lukas Streich
Philipp W. Raess
Theodore Braun

Frontiers in Oncology

doi 10.3389/fonc.2023.1217153

2,353 views
2 citations

Mini Review

Published on 06 Sep 2023

Cancer-associated fibroblasts in hematologic malignancies: elucidating roles and spotlighting therapeutic targets

in Hematologic Malignancies

Ziyang Ding
Run Shi
Weikang Hu
Lei Tian
Rong Sun
Yang Wu
Xiaoyan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1193978

4,933 views
12 citations

Original Research

Published on 31 Aug 2023

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy

in Hematologic Malignancies

Fortunato Morabito
Carlo Adornetto
Paola Monti
Adriana Amaro
Francesco Reggiani
Monica Colombo
Yissel Rodriguez-Aldana
Giovanni Tripepi
Graziella D’Arrigo
Claudia Vener

Frontiers in Oncology

doi 10.3389/fonc.2023.1198992

6,141 views
11 citations

Editorial

Published on 30 Aug 2023

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

in Hematologic Malignancies

Hanno Maximilian Witte
Axel Künstner
Emil Chteinberg
Francesco Piazza
Gaël Roué
Niklas Gebauer

Frontiers in Oncology

doi 10.3389/fonc.2023.1278169

1,807 views

Review

Published on 30 Aug 2023

Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?

in Hematologic Malignancies

Samuel C. F. Couto
Ariel Kowes
Camila S. Aurabi
Theo G. M. Oliveira
Paulo Klinger
Vanderson Rocha

Frontiers in Oncology

doi 10.3389/fonc.2023.1195759

5,648 views
1 citation

Case Report

Published on 28 Aug 2023

Intravitreal methotrexate in type B lymphoblastic leukemia—Case Report

in Hematologic Malignancies

Maria Isabel Maya Naranjo
Sebastián Vallejo López
Sara Mesa Mesa
Mónica Ortiz Pérez
Mariana López Posada
Martha Lía Gaviria Bravo
María Elena González Alviar

Frontiers in Oncology

doi 10.3389/fonc.2023.1237204

3,003 views
2 citations

Original Research

Published on 28 Aug 2023

Establishment of a primary renal lymphoma model and its clinical relevance

in Hematologic Malignancies

Xiaoxi Li
Minyao Deng
Chenxiao Zhang
Lingli Luo
Hui Qian

Frontiers in Oncology

doi 10.3389/fonc.2023.1089187

2,964 views
5 citations